News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,017 Results
Type
Article (46253)
Company Profile (301)
Press Release (670463)
Section
Business (208992)
Career Advice (2232)
Deals (36285)
Drug Delivery (107)
Drug Development (82573)
Employer Resources (177)
FDA (16312)
Job Trends (15236)
News (352823)
Policy (33189)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2584)
Accelerated approval (2)
Adcomms (25)
Allergies (81)
Alliances (50910)
ALS (90)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (120)
Approvals (16302)
Artificial intelligence (245)
Autoimmune disease (19)
Automation (14)
Bankruptcy (370)
Best Places to Work (11733)
BIOSECURE Act (19)
Biosimilars (104)
Biotechnology (221)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (251)
Cancer (2055)
Cardiovascular disease (173)
Career advice (1850)
Career pathing (31)
CAR-T (151)
Cell therapy (426)
Cervical cancer (19)
Clinical research (66883)
Collaboration (810)
Compensation (456)
Complete response letters (24)
COVID-19 (2629)
CRISPR (40)
C-suite (222)
Cystic fibrosis (101)
Data (1985)
Decentralized trials (2)
Denatured (20)
Depression (44)
Diabetes (250)
Diagnostics (6402)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (115)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (88)
Earnings (87098)
Editorial (34)
Employer branding (21)
Employer resources (152)
Events (115514)
Executive appointments (665)
FDA (17439)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (716)
Gene editing (105)
Generative AI (21)
Gene therapy (307)
GLP-1 (719)
Government (4431)
Grass and pollen (4)
Guidances (48)
Healthcare (18949)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2764)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (89)
Interviews (356)
IPO (16796)
IRA (42)
Job creations (3928)
Job search strategy (1590)
Kidney cancer (10)
Labor market (34)
Layoffs (474)
Leadership (18)
Legal (8108)
Liver cancer (70)
Lung cancer (293)
Lymphoma (136)
Machine learning (4)
Management (61)
Manufacturing (284)
MASH (62)
Medical device (13369)
Medtech (13374)
Mergers & acquisitions (19957)
Metabolic disorders (656)
Multiple sclerosis (73)
NASH (18)
Neurodegenerative disease (91)
Neuropsychiatric disorders (28)
Neuroscience (1885)
NextGen: Class of 2025 (6673)
Non-profit (4523)
Northern California (2462)
Now hiring (38)
Obesity (353)
Opinion (246)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (78)
Parkinson's disease (138)
Partnered (21)
Patents (207)
Patient recruitment (95)
Peanut (47)
People (58793)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20933)
Phase II (29507)
Phase III (21858)
Pipeline (1073)
Podcasts (66)
Policy (120)
Postmarket research (2587)
Preclinical (8850)
Press Release (72)
Prostate cancer (94)
Psychedelics (35)
Radiopharmaceuticals (248)
Rare diseases (381)
Real estate (6256)
Recruiting (67)
Regulatory (22628)
Reports (46)
Research institute (2373)
Resumes & cover letters (376)
Rett syndrome (3)
RNA editing (4)
RSV (41)
Schizophrenia (68)
Series A (128)
Series B (84)
Service/supplier (14)
Sickle cell disease (55)
Southern California (2129)
Special edition (15)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3826)
State (2)
Stomach cancer (14)
Supply chain (61)
The Weekly (44)
United States (21597)
Vaccines (686)
Venture capitalists (39)
Webinars (12)
Weight loss (241)
Women's health (33)
Worklife (17)
Date
Today (143)
Last 7 days (745)
Last 30 days (2817)
Last 365 days (34324)
2025 (8334)
2024 (36002)
2023 (40707)
2022 (51899)
2021 (56368)
2020 (54689)
2019 (47153)
2018 (35599)
2017 (33139)
2016 (32595)
2015 (38465)
2014 (33845)
2013 (28963)
2012 (29450)
2011 (30119)
2010 (28199)
Location
Africa (801)
Alabama (49)
Alaska (7)
Arizona (227)
Arkansas (13)
Asia (39723)
Australia (6670)
California (5622)
Canada (1881)
China (492)
Colorado (250)
Connecticut (261)
Delaware (130)
Europe (86450)
Florida (828)
Georgia (194)
Idaho (57)
Illinois (526)
India (24)
Indiana (294)
Iowa (9)
Japan (145)
Kansas (104)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (847)
Massachusetts (4264)
Michigan (210)
Minnesota (380)
Mississippi (2)
Missouri (77)
Montana (30)
Nebraska (26)
Nevada (57)
New Hampshire (63)
New Jersey (1618)
New Mexico (29)
New York (1616)
North Carolina (955)
North Dakota (7)
Northern California (2462)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1275)
Puerto Rico (9)
Rhode Island (26)
South America (1188)
South Carolina (18)
South Dakota (1)
Southern California (2129)
Tennessee (93)
Texas (839)
Utah (168)
Virginia (134)
Washington D.C. (57)
Washington State (523)
West Virginia (3)
Wisconsin (50)
717,017 Results for "moleculin biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Moleculin to Present at the MedInvest Biotech & Pharma Investor Conference
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company) today announced Walter Klemp, President and Chief Executive Officer of Moleculin will present at the MedInvest Biotech & Pharma Investor Conference behind held in New York City, NY on Thursday, April 4, 2024 at 4:10 PM ET.
March 28, 2024
·
2 min read
Press Releases
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
April 1, 2025
·
6 min read
Press Releases
Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update
March 25, 2025
·
11 min read
Lone Star Bio
Moleculin to Participate in the Virtual Investor Lunch Break: The Moleculin Opportunity
Moleculin Biotech, Inc. announced that it will present at the Virtual Investor Lunch Break: The Moleculin Opportunity event on Thursday, March 28, 2024 at 12:00 PM ET.
March 27, 2024
·
2 min read
Lone Star Bio
Moleculin to Present at the Virtual Investor Pitch Conference - June 12, 2024
Moleculin Biotech, Inc. announced that it will present at the Virtual Investor Pitch Conference on June 18, 2024 at 3:00 PM ET.
June 12, 2024
·
2 min read
Press Releases
Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast
March 19, 2025
·
2 min read
Lone Star Bio
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial
Moleculin Biotech, Inc. reported additional efficacy findings from the Company’s ongoing Phase 1B/2 clinical trial evaluating Annamycin in combination with Cytarabine for the treatment of subjects with acute myeloid leukemia.
June 14, 2024
·
7 min read
Business
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
Moleculin Biotech, Inc. today announced the formation of its Annamycin Scientific Advisory Board and inaugural appointment of Dr. Martin Tallman.
May 1, 2024
·
5 min read
Pharm Country
Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor “What This Means” Segment Hosted by JTC Team
JTC Team (“JTC”), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor “What This Means” segment featuring Moleculin Biotech (NASDAQ:MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses.
April 25, 2024
·
1 min read
Lone Star Bio
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company) today announced it has received an Issue Notification from the United States Patent and Trademark Office (USPTO) for U.S. Patent number 11,980,634 titled, “Method of Reconstituting Liposomal Annamycin” (the ‘634 patent’) to be issued on May 14, 2024 to Moleculin and The University of Texas System Board of Regents.
May 9, 2024
·
5 min read
1 of 71,702
Next
